Document:

Option Agreement dated as of November 13, 2007

 Exhibit 10.8 
 EXECUTION VERSION 
  

			
		  	OPTION AGREEMENT (this “Agreement”) dated as of November 13, 2007 between DOMUS HOLDINGS CORP., a Delaware corporation, (the “Company”) and
OPTIONEE (as set forth on the signature page hereto, the “Optionee”).

 WHEREAS, the Company, acting through the Committee with the consent of the Company’s
Board of Directors (the “Board”) will grant to the Optionee, effective as of the date hereof (the “Grant Date”), an option under the Domus Holdings Corp. 2007 Stock Incentive Plan (the “Plan”) to
purchase a number of shares of Common Stock (“Shares”) on the terms and subject to the conditions set forth in this Agreement and the Plan; 
 WHEREAS, in connection with entry into this Agreement, the Optionee has adopted, and become party to, the Management Investor Rights Agreement by and between the Company and certain holders of Shares, dated as
of April 10, 2007 (the “Management Investor Rights Agreement”); 
 NOW, THEREFORE, in consideration of the
promises and of the mutual agreements contained in this Agreement, the parties hereto hereby agree as follows: 
 Section 1. The
Plan. The terms and provisions of the Plan are hereby incorporated into this Agreement as if set forth herein in their entirety. In the event of a conflict between any provision of this Agreement and the Plan, the provisions of the Plan shall
control. A copy of the Plan may be obtained from the Company by the Optionee upon request. Capitalized terms used herein and not otherwise defined herein shall have the respective meanings ascribed thereto in the Plan. 
 Section 2. Option; Option Price. Effective on the Grant Date, on the terms and subject to the conditions of the Plan and this Agreement, the
Company hereby grants to the Optionee the option (the “Option”) to purchase Shares pursuant to Tranche A options (“Tranche A Options”), Tranche B options (“Tranche B Options”), and Tranche C options
(“Tranche C Options”) at the price per Share (the “Option Price”) and in the amounts set forth on the signature page hereto. Payment of the Option Price may be made in any manner permitted by the Committee under
Section 5.6 of the Plan; provided that, in addition to the manners permitted under Section 5.6 of the Plan, upon the exercise of Options granted under the Plan by the Optionee in respect of 250,000 Shares or more in a single
transaction, the Optionee may direct the Company to deduct from the Shares issuable upon exercise of such Options a number of Shares having an aggregate Fair Market Value equal to the sum of the aggregate Option Price in respect of the Options being
exercised, and the Company shall thereupon issue to the Optionee the net remaining number of Shares after such deduction. The Option is not intended to qualify for federal income tax purposes as an “incentive stock option” within the
meaning of Section 422 of the Code. 
 Section 3. Term. The term of the Option (the “Option Term”) shall
commence on the Grant Date and expire on the tenth anniversary of the Grant Date, unless the Option shall have sooner been terminated in accordance with the terms of the Plan (including, without limitation, Article 5 of the Plan) or this
Agreement (including, without limitation, Section 7 of this Agreement). 

 Section 4. Vesting. Except as otherwise set forth in Section 7 (including,
without limitation, Section 7(b)), the Options shall become non-forfeitable (any Options that shall have become non-forfeitable pursuant to Section 4, the “Vested Options”) and shall become exercisable according to
the following provisions, subject to the Optionee’s continued employment with the Company as of any such date (except as otherwise provided below): 
 (a) Tranche A Options. Twenty-percent (20%) of the Tranche A Options shall become Vested Options and shall become exercisable on each of the first five anniversaries of September 1, 2007; provided,
however, that in the event of the Optionee’s Termination of Relationship by the Company without Cause, all the then unvested Tranche A Options shall become Vested Options and shall become exercisable as of the Optionee’s date of
Termination of Relationship. In the event of a Sale of the Company, each Tranche A Option that has not theretofore become a Vested Option pursuant to the immediately preceding sentence and is outstanding as of immediately prior to the consummation
of such Sale of the Company (each such Option, a “CIC Vesting Tranche A Option”) shall vest in full effective as of the consummation of such Sale of the Company, and the Optionee shall be entitled to receive an amount equal to the
Spread Value (defined below) to be payable at the same time(s), in the same form(s) of consideration (e.g., cash, securities or other property or a combination thereof) and subject to the same terms and conditions as are applicable to the
consideration paid with respect to Shares held by the shareholders of the Company (the “Shareholders”) in the Sale of the Company as set forth in the agreement pursuant to which the Sale of the Company is effectuated. The treatment
of the CIC Vesting Tranche A Options upon a Sale of the Company as set forth in this Section 4(a) shall be in lieu of any adjustments or other rights that may otherwise apply to other option holders under the Plan, including without limitation
any adjustments or other rights under Article X of the Plan. 
 (b) Tranche B Options. All of the Tranche B Options shall
become Vested Options in the event the Investor IRR equals or exceeds 20% (the “Tranche B Targets”); provided, however, that in the event of the Optionee’s Termination of Relationship by the Company without Cause, the Tranche B
Options (to the extent then unvested) shall continue to be eligible to become Vested Options and exercisable based upon the subsequent achievement of the Tranche B Targets. 
 (c) Tranche C Options. All of the Tranche C Options shall become Vested Options in the event the Investor IRR equals or exceeds 25% (the
“Tranche C Targets”) provided, however, that in the event of the Optionee’s Termination of Relationship by the Company without Cause, the Tranche C Options (to the extent then unvested) shall continue to be eligible to become
Vested Options and exercisable based upon the subsequent achievement of the Tranche C Targets. 
 (d) Exercise of Vested Tranche B and
Tranche C Options. Immediately prior to the consummation of a Sale of the Company, the Optionee’s Tranche B Options and Tranche C Options that have previously, or will upon consummation of such Sale, become Vested Options (collectively, the
“Vested IRR Options”), shall automatically be exercised and converted 

  

 -2- 

 
into Shares, with such exercise being effectuated by the Company deducting from the Shares issuable upon such exercise a number of Shares having an aggregate
Fair Market Value equal to the sum of (i) the aggregate Option Price payable in respect of such Vested IRR Options and (ii) the minimum tax withholding due upon exercise of such Vested IRR Options. The Company shall thereupon issue to the
Optionee the net remaining number of Shares after such deductions in order to allow the Optionee to participate in such transaction in the same manner as other Shareholders generally. 
 (e) Committee Determinations. All decisions by the Committee with respect to any calculations pursuant to this Section 4 (absent
manifest error), including the Investor IRR and the dates the Investor IRR is equal to or exceeds 20% or 25%, shall be final and binding on the Optionee. 
 (f) Definitions. 
 “Spread Value” means the product of (i) the number of Shares
subject to the CIC Vesting Tranche A Options and (ii) the excess (if any) of (x) the value per share payable in respect of the Shares of the Company to Shareholders in the Sale of the Company, over (y) the Option Price (as in effect
on the day immediately prior to the consummation of such Sale of the Company) per each Share subject to the CIC Vesting Tranche A Options. For purposes of the foregoing, (A) if the Shareholders receive cash in respect of their Shares, then the
Spread Value, if any, shall be measured and payable in cash based on the per share cash amount paid to Shareholders in connection with the Sale of the Company; (B) if the Shareholders receive securities or other property in respect of their
Shares, then the Spread Value, if any, shall be measured and payable in the form of such securities or other property, with the amount of the securities or other property, if any, that the Optionee receives in respect of the CIC Vesting Tranche A
Options being equal to the securities or other property that the Optionee would have received if the CIC Vesting Tranche A Options had been exercised immediately prior to the Sale of the Company and the aggregate Option Price (as in effect on the
day immediately prior to the consummation of such Sale of the Company) for such Options was paid in Shares as permitted under Section 2 of this Agreement (with the number of Shares withheld for purposes of paying the aggregate Option Price
determined pursuant to the same method required to be used to determine the Fair Market Value of the Shares); and (C) if the Shareholders receive a combination of the two foregoing forms of consideration, then the Spread Value shall be measured
and payable in cash and securities or other property in the same per Share proportion as is paid to the Shareholders and otherwise consistent with the principles set forth in clauses (A) and (B) above. 
 Section 5. Restriction on Transfer. The Option may not be transferred, pledged, assigned, hypothecated or otherwise disposed of in any way by
the Optionee and (unless the Optionee becomes subject to a Disability) may be exercised during the lifetime of the Optionee only by the Optionee. If the Optionee dies or becomes subject to a Disability, the Option shall thereafter be exercisable,
during the period specified in Section 7 of this Agreement, by his beneficiary, or if no beneficiary has been named, by his executors or administrators to the full extent to which the Option was exercisable by the Optionee at the time of
his death or Disability. The Option shall not be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation or other disposition of the Option contrary to the 

  

 -3- 

 
provisions hereof, and the levy of any execution, attachment or similar process upon the Option, shall be null and void and without effect. Notwithstanding
the foregoing, the Optionee may assign or transfer the Option with the prior consent of the Committee to a “family member” as such term is defined in Rule 701 of the Securities Act (each transferee thereof, a “Permitted
Assignee”), provided that such Permitted Assignee shall be bound by and subject to all of the terms and conditions of the Plan and the Option Agreement relating to the transferred Option and shall execute an agreement satisfactory to
the Company evidencing such obligations, and provided, further that the Optionee shall remain bound by the terms and conditions of the Plan and the Management Investor Rights Agreement. The Company shall cooperate with any Permitted
Assignee and the Company’s transfer agent in effectuating any transfer permitted under this Section 5. 
 Section 6.
Optionee’s Service. Nothing in this Agreement or in the Option shall confer upon the Optionee any right to continue as an employee of, or other service provider to, the Company or any of its Subsidiaries or Affiliates or interfere in any
way with the right of the Company, its Subsidiaries or its Affiliates, as the case may be, in their respective sole discretion, to terminate the Optionee’s employment or service relationship or to increase or decrease the Optionee’s
compensation at any time. 
 Section 7. Termination. (a) The Option shall automatically terminate and shall become null and
void, be unexercisable and be of no further force and effect upon the earlier of: (a) the tenth anniversary of the Grant Date or (b) (i) in the event of a Termination of Relationship prior to the occurrence of a Qualified Public
Offering, the two-year anniversary of the Termination of Relationship and (ii) in the event of a Termination of Relationship on or after the occurrence of a Qualified Public Offering, the one-year anniversary of the Termination of Relationship;
provided, however, that with respect to Tranche B Options and Tranche C Options that continue to be eligible to vest following a Termination of Relationship by the Company without Cause as provided for in Sections 4(b) and 4(c) above, if the Tranche
B Targets or Tranche C Targets, as applicable, are achieved following the occurrence of the date of the Termination of Relationship by the Company without Cause and prior to the tenth anniversary of the Grant Date, such Tranche B Options and/or
Tranche C Options shall remain exercisable until the earlier of the tenth anniversary of the Grant Date and the time periods set forth in subclause (b)(i) or (b)(ii) above (provided that such exercise periods shall be measured from the date of
achievement of the applicable targets, rather than from the date of the Termination of Relationship by the Company without Cause), as applicable, depending on whether the achievement of the applicable performance target occurred prior to, or on or
after, a Qualified Public Offering. Notwithstanding the foregoing, the Option shall automatically terminate and shall become null and void, be unexercisable and be of no further force and effect upon the day of the Termination of Relationship in the
case of a Termination of Relationship with Cause. 
 (b) Except as otherwise provided in the Plan, upon a Termination of Relationship for any
reason, the unvested portion of the Option (i.e., that portion which does not constitute Vested Options) shall immediately terminate and be forfeited on the date the Termination of Relationship occurs. 
 Section 8. Securities Law Representations. The Optionee acknowledges that the Option and the Shares are not being registered under the
Securities Act, based, in part, in reliance 

  

 -4- 

 
upon an exemption from registration under Rule 701 or Regulation D promulgated under the Securities Act, and a comparable exemption from qualification under
applicable state securities laws, as each may be amended from time to time. The Optionee, by executing this Agreement, hereby makes the following representations to the Company and acknowledges that the Company’s reliance on federal and state
securities law exemptions from registration and qualification is predicated, in substantial part, upon the accuracy of these representations: 
  

	 	•	 	 The Optionee is acquiring the Option and, if and when he exercises the Option, will acquire the Shares solely for the Optionee’s own account, for investment
purposes only, and not with a view or an intent to sell, or to offer for resale in connection with any unregistered distribution, all or any portion of the shares within the meaning of the Securities Act and/or any applicable state securities laws.

  

	 	•	 	 The Optionee is an “accredited investor,” as that term is defined in Rule 501(a)(1), (2) or (3) of Regulation D promulgated under the Securities
Act. 

  

	 	•	 	 The Optionee has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the Option and the restrictions
imposed on any Shares purchased upon exercise of the Option. The Optionee has been furnished with, and/or has access to, such information as the Optionee considers necessary or appropriate for deciding whether to exercise the Option and purchase the
Shares. However, in evaluating the merits and risks of an investment in the Shares, the Optionee has and will rely only upon the advice of the Optionee’s own legal counsel, tax advisors, and/or investment advisors. 

 

	 	•	 	 The Optionee acknowledges that to the best of his knowledge the Option Price is not less than what the Board has determined to be the Fair Market Value of the
Shares. 

  

	 	•	 	 The Optionee is aware that any value of the Option depends on its vesting and exercisability as well as an increase in the Fair Market Value and certain other
factors of the underlying Shares to an amount in excess of the Option Price, and that any investment in common shares of a closely held corporation such as the Company is non-marketable, non-transferable and could require capital to be invested for
an indefinite period of time, possibly without return, and at substantial risk of loss. 

  

	 	•	 	 The Optionee understands that any Shares acquired on exercise of the Option will be characterized as “restricted securities” under the federal securities
laws, and that, under such laws and applicable regulations, such securities may be resold without registration under the Securities Act only in certain limited circumstances, including in accordance with the conditions of Rule 144 promulgated under
the Securities Act, as presently in effect. The Optionee acknowledges receiving a copy of Rule 144 promulgated under the Securities Act, as presently in effect, and represents that the Optionee is familiar with such rule, and understands the resale
limitations imposed thereby and by the Securities Act and the applicable state securities law. 

  

 -5- 

	 	•	 	 The Optionee has read and understands the restrictions and limitations set forth in the Management Investor Rights Agreement, the Plan and this Agreement. The
Optionee acknowledges that to the extent the Optionee is not a party to the Management Investor Rights Agreement at the time that the Optionee exercises any portion of the Option, such exercise shall be treated for all purposes as effecting the
Optionee’s simultaneous execution of the Management Investor Rights Agreement and the Optionee shall be bound thereby. 

  

	 	•	 	 The Optionee has not relied upon any oral representation made to the Optionee relating to the Option or the purchase of the Shares on exercise of the Option or upon
information presented in any promotional meeting or material relating to the Option or the Shares. 

  

	 	•	 	 The Optionee understands and acknowledges that, if and when he exercises the Option, (a) any certificate evidencing the Shares (or evidencing any other
securities issued with respect thereto pursuant to any stock split, stock dividend, merger or other form of reorganization or recapitalization) when issued shall bear any legends which may be required by applicable federal and state securities laws,
and (b) except as otherwise provided under the Management Investor Rights Agreement, the Company has no obligation to register the Shares or file any registration statement under federal or state securities laws. The Committee reserves the
right to account for Shares through book entry or other electronic means rather than the issuance of stock certificates. 

 Section 9. Designation of Beneficiary. The Optionee may appoint any individual or legal entity in writing as his beneficiary to receive any Option (to the extent not previously terminated or forfeited) under this Agreement upon
the Optionee’s death or becoming subject to a Disability. The Optionee may revoke his designation of a beneficiary at any time and appoint a new beneficiary in writing. To be effective, the Optionee must complete the designation of a
beneficiary or revocation of a beneficiary by written notice to the Company under Section 11 of this Agreement before the date of the Optionee’s death. In the absence of a beneficiary designation, the legal representative of the
Optionee’s estate shall be deemed the Optionee’s beneficiary. 
 Section 10. Notices. All notices, claims,
certifications, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given and delivered if personally delivered or if sent by nationally-recognized overnight courier, by telecopy, or by
registered or certified mail, return receipt requested and postage prepaid, addressed as follows: 
  

 -6- 

 If to the Company, to it at: 
 Domus Holdings Corp. 
 c/o Apollo Management
VI, L.P. 
 9 West 57th Street 
 New York, New York 10019 
 Facsimile: (212) 515-3264 
 Attention:
Marc Becker 
 With a copy to (which copy will not constitute notice): 
 Wachtell, Lipton, Rosen & Katz 
 51 West 52nd Street 
 New York, NY 10019 
 Attention: Steven A. Cohen, Esq. 
       Igor Kirman, Esq. 
 Facsimile: 212.403.2000 
 If to the Optionee, at the address
set forth on the signature page hereto; or to such other address as the party to whom notice is to be given may have furnished to the other party in writing in accordance herewith. Any such notice or other communication shall be deemed to have been
received (a) in the case of personal delivery, on the date of such delivery (or if such date is not a business day, on the next business day after the date of delivery), (b) in the case of nationally-recognized overnight courier, on the
next business day after the date sent, (c) in the case of telecopy transmission, when received (or if not sent on a business day, on the next business day after the date sent), and (d) in the case of mailing, on the third business day
following that on which the piece of mail containing such communication is posted. 
 Section 11. Waiver of Breach. The waiver by
either party of a breach of any provision of this Agreement must be in writing and shall not operate or be construed as a waiver of any other or subsequent breach. 
 Section 12. Optionee’s Undertaking. The Optionee hereby agrees to take whatever additional actions and execute whatever additional documents the Company may in its reasonable judgment deem necessary
or advisable in order to carry out or effect one or more of the obligations or restrictions imposed on the Optionee pursuant to the express provisions of this Agreement and the Plan. 
 Section 13. Modification of Rights. The rights of the Optionee are subject to modification and termination in certain events as provided in
this Agreement and the Plan (with respect to the Options granted hereby). Notwithstanding the foregoing, the Optionee’s rights under this Agreement and the Plan may not be materially impaired without the Optionee’s prior written consent.

 Section 14. Governing Law. THIS AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
DELAWARE, WITHOUT GIVING EFFECT TO ANY CHOICE OR CONFLICT OF LAW PROVISION OR 

  

 -7- 

 
RULE (WHETHER OF THE STATE OF DELAWARE OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF DELAWARE TO BE
APPLIED. IN FURTHERANCE OF THE FOREGOING, THE INTERNAL LAW OF THE STATE OF DELAWARE WILL CONTROL THE INTERPRETATION AND CONSTRUCTION OF THIS AGREEMENT, EVEN IF UNDER SUCH JURISDICTION’S CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE
LAW OF SOME OTHER JURISDICTION WOULD ORDINARILY APPLY. 
 Section 15. Restrictive Covenants. The grant, vesting and exercise of
Options pursuant to this Agreement shall be subject to the Optionee’s continued compliance with the restrictive covenants set forth in the Term Sheet by and among the Optionee, the Company and Realogy Corporation, dated as of November 13,
2007, and the provisions in Annex I of the Management Investor Rights Agreement shall be inapplicable to the Optionee. 
 Section 16.
Withholding. As a condition to exercising this Option in whole or in part, the Optionee will pay, or make provisions satisfactory to the Company for payment of, any Federal, state and local taxes required to be withheld in connection with
such exercise; provided, however, subject to such exercise satisfying the minimum threshold for the payment with Shares of the Option Price as set forth in Section 2 above, the Optionee (or the Optionee’s estate, as
applicable) may direct the Company to deduct from the Shares issuable upon exercise of all (and not less than all) of the Optionee’s then exercisable Options a number of Shares having an aggregate Fair Market Value equal to the minimum tax
withholding due upon exercise of such Options. 
 Section 17. Adjustment. In the event of any event described in Article X of the
Plan occurring after the Grant Date, the adjustment provisions (including cash payments) as provided for under Article X of the Plan shall apply. Notwithstanding any provisions of Article X of the Plan, Section 4(d) of this Agreement shall
apply with respect to the treatment of Vested IRR Options in connection with a Sale of the Company. 
 Section 18. Counterparts.
This Agreement may be executed in one or more counterparts, and each such counterpart shall be deemed to be an original, but all such counterparts together shall constitute but one agreement. 
 Section 19. Entire Agreement. This Agreement and the Plan (and the other writings referred to herein) constitute the entire agreement between
the parties with respect to the subject matter hereof and thereof and supersede all prior written or oral negotiations, commitments, representations and agreements with respect thereto. 
 Section 20. Severability. It is the desire and intent of the parties hereto that the provisions of this Agreement be enforced to the fullest
extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid,
prohibited or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other
jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or 

  

 -8- 

 
unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement
or affecting the validity or enforceability of such provision in any other jurisdiction. 
 Section 21. Waiver of Jury Trial.
Each party hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, trial by jury in any suit, action or proceeding arising hereunder. 
 Section 22. Code Section 409A. Notwithstanding anything herein or elsewhere to the contrary, to the extent the Optionee or the Company
notifies the other that this Agreement may reasonably be expected to result in the Optionee’s being subject to the penalties of Section 409A of the Code, the Optionee and the Company agree to negotiate (and the Company shall cause any
affiliate to negotiate) in good faith alternatives to avoid such penalties. 
 [Signature Pages Follow] 
  

 -9- 

 IN WITNESS WHEREOF, the parties hereto have executed this Option Agreement as of the date first
written above. 
  

					
		  	DOMUS HOLDINGS CORP.
			
		  	By:	  	 /s/ Richard A. Smith

		  	Name:	  	Richard A. Smith
		  	Title:	  	President and Chief Executive Officer
		
		  	OPTIONEE
		
		  	See attached signature page

  

 -10- 

					
		  	OPTIONEE
			
		  		  	 /s/ Henry R. Silverman

		  	Name:	  	Henry R. Silverman
		
		  	Residence Address:
		
	Number of Shares of Common Stock subject to Tranche A Options:	  	2,500,000
		
	Number of Shares of Common Stock subject to Tranche B Options:	  	1,250,000
		
	Number of Shares of Common Stock subject to Tranche C Options:	  	1,250,000
		
	Option Price for Tranche A Options, Tranche B Options, and Tranche C Options:	  	$10.00 each

  

 -11-Employment Agreement with Richard A. Smith

 Exhibit 10.9 
  

			
		  	 EMPLOYMENT AGREEMENT (this
 “Agreement”) dated as of April 10, 2007, between 
 REALOGY CORPORATION, a Delaware
 corporation, (the “Company”) and RICHARD A.
 SMITH (“Executive”).

 WHEREAS, pursuant to the Agreement and Plan of Merger, made and entered into as of the 15th
day of December, 2006, by and among Domus Holdings Corp. (the “Parent”), the Company and Domus Acquisition Corp. (the “Merger Agreement”), Domus Acquisition Corp. will be merged with and into the Company (the
“Transaction”), and the Company will be the surviving corporation in the Transaction; 
 WHEREAS, in connection with
the Transaction, the Company desires to employ Executive and Executive desires to be employed by the Company; 
 WHEREAS, the Company
and Executive are parties to that certain employment agreement dated as of the effective date of the spin-off of the Company from Cendant Corporation, a Delaware corporation, as such employment agreement has been amended or supplemented through the
Effective Date (as defined in Section 1) (the “Prior Agreement”); and 
 WHEREAS, Executive, as a condition of
his employment, will make a substantial investment in the Parent concurrently with the closing of the Transaction by purchasing 830,000 shares of common stock of the Parent, par value $0.01 (“Common Stock”), at a price of $10.00 per
share; 
 NOW THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 Section 1. Employment Period.

 The initial term of Executive’s employment hereunder shall be for a period of five (5) years (the “Initial
Term”) commencing on the closing of the Transaction (the “Effective Date”) and ending on the fifth anniversary of the Effective Date, unless terminated earlier pursuant to Section 3 (the “Employment
Period”); provided, however, that the Employment Period shall automatically be renewed for an additional period of one (1) year upon the expiration of the Initial Term unless either party gives at least ninety
(90) days’ written notice of its intention not to renew the Employment Period. Upon Executive’s termination of employment with the Company for any reason, he shall immediately resign all positions with the Company or any of its
subsidiaries or affiliates, including any position as a member of the Parent’s Board of Directors and a member of the Company’s Board of Directors (the “Board”). 
 Section 2. Terms of Employment. 
 (a) Position. During the term of Executive’s employment under this Agreement, Executive shall serve as Vice Chairman and President of the Company and, effective as of January 1, 2008 (or such earlier date as the
Company’s current Chief Executive Officer 

 
ceases serving in such position), Chief Executive Officer of the Company and shall have such duties and responsibilities as shall be assigned to Executive by
the Board. In performing his duties hereunder, Executive shall report directly to the Board. Executive shall also serve as a member of the Board during the Employment Period. At the request of the Company, Executive shall also serve as an officer of
any of its subsidiaries or affiliates without additional compensation. 
 (b) Duties. During the Employment Period, Executive agrees
to devote all of his business time to the business and affairs of the Company and to use Executive’s reasonable best efforts to perform faithfully, effectively and efficiently his responsibilities and obligations hereunder. Notwithstanding the
foregoing, nothing herein shall prohibit Executive from (i) serving on civic or charitable boards or committees and (ii) managing personal investments, so long as such activities do not materially interfere with the performance of
Executive’s responsibilities hereunder. 
 (c) Compensation. 
 (i) Base Salary. During the Employment Period, Executive shall receive an initial annual base salary in an amount equal to $1,000,000.00, which
shall be paid in accordance with the customary payroll practices of the Company (the “Annual Base Salary”). Executive’s Annual Base Salary shall be reviewed at least annually by the Board but may not be reduced. 
 (ii) Bonuses. The Company shall establish a performance-based bonus plan (the “Plan”) to be applicable for each fiscal year of
the Company (a “Fiscal Year”) ending during the Employment Period pursuant to which Executive will be eligible to receive an annual bonus (the “Bonus”) with respect to each Fiscal Year of the Company ending during
the Employment Period (each, a “Bonus Year”). The Board or the Compensation Committee of the Board (the “Compensation Committee”) will administer the Plan and, in consultation with Executive, shall establish
performance objectives for each Fiscal Year, which performance objectives shall be reasonably related to the Company’s business objectives. In the event that, with respect to the applicable Fiscal Year of the Company ending during the
Employment Period, the Company achieves the pre-established target performance goals based on actual performance, Executive shall be entitled to receive a Bonus in an amount equal to 200% of Executive’s Annual Base Salary (“Target
Bonus”). Subject to Section 4, Executive will be entitled to receive the Bonus only upon the Company’s achievement of the specified performance objectives and if Executive is employed on the last day of the applicable Bonus Year.
The Bonus shall become payable on March 15 of the year following the end of the applicable Bonus Year, provided that the Board or Compensation Committee finally determines (x) that the Company has achieved the applicable performance
objectives and (y) the amount of the bonus that shall be paid to each executive entitled to receive a bonus for the applicable Bonus Year. If the Board or Compensation Committee has not made such final determination by March 15 of such
year, the Bonus (if any) shall instead be paid as soon as practicable thereafter during such year. 
  

 -2- 

 (iii) Benefits. 
 (1) During the Employment Period, Executive shall be entitled to participate in all incentive, savings and retirement plans, practices, policies and programs applicable generally to other senior executives of the
Company and shall be eligible for participation in, and shall receive all benefits under, welfare benefit plans, practices, policies and programs provided by the Company to the extent applicable generally to other senior executives of the Company
(“Benefit Plans”). The benefits provided to Executive shall be, in the aggregate, comparable to those benefits that Executive was receiving at the Company immediately prior to the Effective Date, but excluding those benefits under
any nonqualified deferred compensation plans that are being amended or terminated in connection with the Transaction or that relate to or provide benefits or compensation measured with respect to the Company’s common stock. In addition to the
foregoing, the Company shall continue to maintain the life insurance policy arrangement (pursuant to which the Company issues Executive a bonus payment, the net- after-tax proceeds of which are sufficient to pay the amount of the premiums due on
such policy) on the same terms and conditions under which the Company maintains this arrangement prior to the Effective Date. 
 (2) The
Company (and any successor to the business of the Company) acknowledges and agrees to provide Executive the following benefits notwithstanding anything in this Agreement to the contrary, and further acknowledges and agrees that this provision shall
survive any termination of Executive’s employment or any termination of this Agreement. In addition to any payments or benefits under the applicable provisions of Section 4 of this Agreement, upon Executive’s termination of employment
from the Company and its subsidiaries for any reason, including, without limitation, due to or following any non-renewal of this Agreement, resignation, or termination by the Company with or without Cause, Executive and each person who is his
covered dependent at such time under each applicable Welfare Benefit Plan (defined below), shall remain eligible to continue to participate in all of such plans (as they may be modified from time to time with respect to all senior executive
officers), or such other welfare benefit plans subsequently made available to senior executive officers of the Company or any successor Company (the “Post-Employment Plans”) until the end of the plan year in which Executive reaches,
or would have reached, age seventy-five (75) (such benefits, the “Post-Employment Benefits”). Executive is currently eligible to participate in the following plans: Executive Physical Exams, Medical Expense Reimbursement Plan
(MERP), Medical Insurance, Dental Insurance, Group Life Insurance (up to $1 million coverage on Executive’s life), Vision Service Plan (collectively, the “Welfare Benefit Plans”). Coverage under such Post-Employment Plans shall
be subject to Executive and/or such dependents, as applicable, continuing to pay the applicable employee portion of any premiums, co-payments, deductibles and similar costs (as if Executive was still an employee of the Company). Solely with respect
to Executive’s dependents, such coverage shall terminate upon such earlier date if and when they become ineligible for any such benefits under the terms of such Welfare Benefit Plans or Post-Employment Plans, as applicable, and provided,
that once Executive or his dependents become eligible for Medicare or any other government-sponsored medical insurance plan, or if Executive is eligible to participate in any other company’s medical insurance plan as an employee after the
termination of his employment, Executive or his dependents shall utilize such government plan or other company plan, and the Company’s insurance obligations as part of the Post-Employment Benefits hereunder shall become secondary to such
government plan or other company plan. Notwithstanding the foregoing, the Company may meet any of its foregoing obligations under the Post-Employment Plans by paying for, or providing for the payment of, such benefits directly 

  

 -3- 

 
or through alternative plans or individual policies which are no less favorable in all material respects (with respect to both coverage and cost to
Executive) to the Post-Employment Plans, provided that the Company shall use its best efforts to assure that provision of the Post-Employments Benefits complies with Section 409A of the Internal Revenue Code of 1986, as amended (the
“Code”). 
 (iv) Expenses. During the term of Executive’s employment, Executive shall be entitled to receive
reimbursement for all reasonable business expenses incurred by Executive in performance of his duties hereunder, provided that Executive provides all necessary documentation in accordance with Company policy. 
 (v) Stock Options. Concurrent with the closing of the Transaction, the Company shall cause the Parent to grant Executive a stock option (the
“Option Grant”) to purchase 3,112,500 shares of Common Stock, at an exercise price of $10.00 per share. The Option Grant will be pursuant and subject to the terms and conditions set forth in the Parent’s 2007 Stock Incentive
Plan (the “Stock Incentive Plan”) and Executive’s option agreement associated with the Option Grant (the “Option Agreement”, which is attached hereto as Appendix [    ]), and
Executive’s purchase of the Purchased Shares as provided in Section 2(c)(vii) below. 
 (vi) Restricted Stock. Concurrent
with the closing of the Transaction, the Company shall cause the Parent to grant Executive a grant (the “Restricted Stock Grant”) of restricted shares of Common Stock (“Restricted Shares”). The Restricted Stock
Grant will be pursuant and subject to the terms and conditions set forth in the Stock Incentive Plan and the restricted stock agreement evidencing such grant (the “Restricted Stock Agreement”, which is attached hereto as Appendix
[    ]). The Restricted Stock Grant will be comprised of 100,000 Restricted Shares and shall be subject to the vesting, termination and other terms set forth in the Restricted Stock Agreement. 
 (vii) Investment. Concurrent with the closing of the Transaction, Executive shall purchase 830,000 shares of Common Stock, at a price of $10.00
per share (the “Purchased Shares”). The Purchased Shares shall be subject to the terms of the Stock Incentive Plan and Executive’s Subscription Agreement (attached hereto as Appendix [    ]) and
Executive’s Contribution Agreements (attached hereto as Appendix [    ]). All of the Purchased Shares will be fully vested at the Effective Date. 
 (viii) Investment Bonus. The Company acknowledges that, in connection with the consummation of the Transaction, Executive is entitled to receive
a one-time bonus in an amount equal to (i) $5 million, less (ii) applicable withholding taxes (such amount, less such taxes, the “Investment Bonus”). Executive hereby elects to receive the Investment Bonus in the form of
fully vested shares of Common Stock (using a per share price equal to $10.00 for purposes of determining the number of such shares), which the Company will deliver to Executive no later than five days after the Effective Date. Executive acknowledges
and agrees that the Common Stock that Executive receives pursuant to the Investment Bonus is in addition to any other purchase of Common Stock that Executive has agreed to make, including without limitation, any such purchase pursuant to the
Subscription Agreement; provided however that the amount invested pursuant to the Investment Bonus shall offset the amounts that Executive is 

  

 -4- 

 
otherwise required to invest. The Investment Bonus shall not be taken into account in computing any benefits or entitlements under any benefit or incentive
plan of the Company or its affiliates or agreement between the Company or any of its affiliates and Executive, including, without limitation, this Agreement, and shall not be subject to deferral. 
 (ix) Management Investor Rights Agreement. All Purchased Shares, shares purchased pursuant to the Investment Bonus, Restricted Shares, the Option
Grant and Common Stock held by Executive pursuant to the vesting of Restricted Shares and the exercise of the Option Grant will be subject to the terms and conditions of the Management Investor Rights Agreement by and among the Parent, Executive,
and other signatories thereto (the “Management Investor Rights Agreement”), including the restrictive covenants contained in Annex I to Section 8 thereof. The Option Agreement, Stock Incentive Plan, Restricted Stock Agreement,
Management Investor Rights Agreement, Subscription Agreement and any other stock or stock-based award agreement entered into by and between the Company and Executive after the date hereof, collectively, (the “Equity Documents”).

 Section 3. Termination of Employment. 
 (a) Death or Disability. Executive’s employment hereunder shall terminate automatically upon Executive’s death. If Executive becomes subject to a Disability during the Employment Period (pursuant to
the definition of Disability set forth below), the Company may give Executive written notice in accordance with Sections 3(e) and 10(h) of its intention to terminate Executive’s employment. For purposes of this Agreement,
“Disability” means (i) Executive’s inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to
last for a continuous period of not less than 12 months, or (ii) Executive is, by reason of any medically determinable physical of mental impairment that can be expected to result in death or can be expected to last for a continuous period of
not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident or health plan covering employees of the Company. Whether Executive has incurred a “Disability” shall be determined
by a physician selected by the Company or its insurers. 
 (b) Cause. Executive’s employment may be terminated at any time by the
Company for Cause. For purposes of this Agreement, “Cause” shall mean (i) Executive’s willful failure to substantially perform his duties as an employee of the Company or any subsidiary (other than any such failure
resulting from incapacity due to physical or mental illness), (ii) any act of fraud, misappropriation, dishonesty, embezzlement or similar conduct against the Company or any subsidiary, (iii) Executive’s conviction of, or plea of
guilty or nolo contendere to a charge of commission of, a felony or crime involving moral turpitude, (iv) Executive’s indictment for a charge of commission of a felony or any crime involving moral turpitude, provided that the Board
determines in good faith that such indictment would result in a material adverse impact to the business or reputation of the Company, (v) Executive’s gross negligence in the performance of his duties, or (vi) Executive purposefully or
negligently makes (or has been found to have made) a false certification to the Company pertaining to its financial statements; a termination will not be for “Cause” pursuant to clause (i), (ii) or (v), to the extent such conduct is
curable, unless the Company shall have notified Executive in writing describing such conduct and Executive shall have failed to cure such conduct within ten (10) business days after his receipt of such written notice. 
  

 -5- 

 (c) Termination Without Cause. The Company may terminate Executive’s employment hereunder
without Cause at any time. 
 (d) Good Reason. Executive’s employment may be terminated at any time by Executive for Good Reason
or without Good Reason upon 90 days’ prior written notice, provided, in the case of a termination for Good Reason, that Executive provides such notice within 60 days after the occurrence of the event giving rise to the termination for Good
Reason. For purposes of this Agreement, “Good Reason” means voluntary resignation after any of the following actions taken by the Company or any of its subsidiaries without Executive’s consent: (i) removal from, or failure
to be elected or re-elected to, the Board; (ii) a material reduction of Executive’s duties and responsibilities to the Company, (iii) a reduction in Executive’s Annual Base Salary or Target Bonus (not including any diminution
related to a broader compensation reduction that (A) is made in consultation with Executive and (B) is applied to all senior executives of the Company in a relatively proportionate matter); (iv) the relocation of Executive’s
primary office to a location more than 30 miles from the prior location; (v) delivery of notice of non-renewal of the Employment Period by the Company (other than non-renewal by the Company due to Executive’s Disability, termination for
Cause or termination by Executive); or (vi) a material breach by the Company of a material provision of this Agreement (which for the avoidance of doubt includes Section 2(a) of this Agreement); a termination shall not be for “Good
Reason” pursuant to clause (i), (ii), (iii) or (iv), unless Executive shall have given written notice of his intention to resign for Good Reason and the Company shall have failed to cure the event giving rise to Good Reason within ten (10
) business days after the Company’s receipt of such written notice. 
 (e) Notice of Termination. Any termination by the Company
for Cause or without Cause, or by Executive for Good Reason or without Good Reason, shall be communicated by Notice of Termination to the other party hereto given in accordance with Section 10(h). For purposes of this Agreement, a
“Notice of Termination” means a written notice that (i) indicates the specific termination provision in this Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances
claimed to provide a basis for termination of Executive’s employment under the provision so indicated and (iii) if the Date of Termination (as defined below) is other than the date of receipt of such notice, specifies the termination date.
The failure by Executive or the Company to set forth in the Notice of Termination any fact or circumstance that contributes to a showing of Good Reason or Cause shall not waive any right of Executive or the Company hereunder or preclude Executive or
the Company from asserting such fact or circumstance in enforcing Executive’s or the Company’s rights hereunder. 
 (f) Date of
Termination. “Date of Termination” means (i) if Executive’s employment is terminated by the Company for Cause, without Cause or by reason of Disability, or by Executive for Good Reason or without Good Reason, the date
of receipt of the Notice of Termination (in the case of a termination with or without Good Reason, provided such notice is in accordance with Section 3(d)) or any later date specified therein pursuant to Section 3(e), as the case may be
and (ii) if Executive’s employment is terminated by reason of death, the date of death. 
  

 -6- 

 Section 4. Obligations of the Company upon Termination. 
 (a) With Good Reason; Without Cause. If during the Employment Period, the Company shall terminate Executive’s employment without Cause or
Executive shall terminate his employment for Good Reason, then the Company will provide Executive with the following severance payments and/or benefits: 
 (i) Prior to the thirtieth day following the Date of Termination, the Company shall pay to Executive in a lump sum, to the extent not previously paid, (i) the Annual Base Salary through the Date of Termination,
and (ii) the Bonus earned for any Bonus Year ended prior to the year in which the Date of Termination occurs, provided that Executive was employed on the last day of such Bonus Year (the “Accrued Obligations”); and 

(ii) The Company will pay Executive an aggregate sum of 300%1 of Executive’s Annual Base Salary and Target Bonus (such amount, the “Cash Severance”) as follows: (i) one-half of the Cash Severance shall be payable to Executive in a lump sum, within 30
business days of the Date of Termination and (ii) 1/72 of the Cash Severance will be payable to Executive in thirty-six (36) equal monthly installments commencing as of the first day of the calendar month following the month in which the
Date of Termination occurs.2 
 Notwithstanding the
foregoing provisions of this Section 4(a), to the extent required in order to comply with Section 409A of the Code, amounts to be paid under this Section 4(a) shall be paid to Executive on the first business day after the date that is
six months following Executive’s “separation from service” within the meaning of Section 409A of the Code. 
 (b)
Death or Disability. If Executive’s employment shall be terminated by reason of Executive’s death or Disability, then the Company will provide Executive (or his estate or legal representative) with the following severance payments
and/or benefits: (A) the Accrued Obligations; (B) a lump sum equal to 100% of Executive’s Annual Base Salary; and (C) the Welfare Benefits. Notwithstanding the foregoing provisions of this Section 4(b), to the extent
required in order to comply with Section 409A of Code, amounts to be paid under this Section 4(b) shall be paid to Executive on the first business day after the date that is six months following Executive’s “separation from
service” within the meaning of Section 409A of the Code. Thereafter, the Company shall have no further obligation to Executive or his legal representatives, other than any rights to vested benefits under any Benefit Plans, indemnification
rights he may have under this Agreement and any rights he may have under the Equity Documents. 
 (c) Cause; Other than for Good
Reason. If Executive’s employment shall be terminated by the Company for Cause or by Executive without Good Reason, then the Company shall have no further payment obligations to Executive other than the Accrued Obligations. 

	1	Other direct reports will have the same multiplier they currently have (100% or 200% (for Hull)). 

	2	Direct reports will have same formulation as Smith, provided that 50% will be paid in 12 (24 for Hull) monthly installments, rather than 36. 

  

 -7- 

 
Thereafter, the Company shall have no further obligation to Executive or his legal representatives, other than any rights to vested benefits under any
Benefit Plans, indemnification rights he may have under this Agreement, and any rights he may have under the Equity Documents. 
 (d)
General Release. The Company’s obligations to make payments under Sections 4(a) and in the case of Disability under Section 4(b) are conditioned on Executive’s or his legal representative’s (as applicable) executing a
general release of claims against the Company and its subsidiaries and affiliates and their successors and assigns (and the officers and directors of such entities) substantially in the form attached hereto as Exhibit A (the
“Release”). For the avoidance of doubt, the Company’s obligations under Section 2(c)(iii)(2), 7 and 9 of this Agreement, the Benefit Plans, and the Equity Documents shall not be subject to Executive’s execution of the
Release nor to Executive’s obligations under Section 5 of this Agreement, unless otherwise specifically provided in such other arrangements. 
 Section 5. Restrictive Covenants. Executive shall be subject to the restrictive covenants set forth in Annex I to Section 8 of the Management Investor Rights Agreement in accordance with its terms,
provided that the restrictive periods set forth in Sections 1 and 2 of such Annex I shall in each case be three years. 
 Section 6. Severance Payments. In addition to the foregoing, and not in any way in limitation of any right or remedy otherwise available to the Company, if the Board reasonably and in good faith believes Executive has violated
or is in violation of any provision of Annex I of the Management Investor Rights Agreement (as modified by Section 5 hereof), the Board may unilaterally suspend Executive’s right to receive any Cash Severance then or thereafter due from
the Company to Executive, provided that the Board (a) gives Executive advance written notice of such suspension and (b) initiates an action or claim to enforce the Company’s rights in respect of such restrictive covenants
promptly after such suspension. In the event that the Company prevails on such action or claim, Executive’s right to receive, and the Company’s obligation to pay, any additional Cash Severance, including any previously suspended amounts,
shall be terminated immediately, and Executive shall have no further rights to Cash Severance. In the event that Executive prevails on such action or claim, the Company shall be required to pay to Executive in a lump sum within thirty (30) days
of such adjudication (or, to the extent required in order to comply with Section 409A of the Code on the first business day after the date that is six months following Executive’s “separation from service” within the meaning of
Section 409A of the Code) any Cash Severance the payment of which was delayed due to such suspension, plus interest for any period during which the payment of the Cash Severance was suspended at the prime rate, as published in the Wall Street
Journal on the date of such suspension, and to commence payment of future installments of Cash Severance in accordance with Section 4(a)(ii). 
 Section 7. Excess Parachute Payments. The provisions of Section X of the Prior Agreement are hereby incorporated by reference and made a part of this Agreement; provided, however, that the references to Section VII
contained therein shall be references to Section 4(a) of this Agreement; provided, further that, in the event that the payments and benefits payable or provided by the Company are eligible for exemption from the definition of
“parachute payment” under Q&A 5 and/or Q&A 6 of Section 1.280G-1 of the Department of Treasury Regulations under the Code (the “280G Regulations”), Executive shall cooperate in good faith with the 

  

 -8- 

 
Company to satisfy such exemptions, which shall include taking such actions as are necessary so that the Company may satisfy the shareholder approval
requirements under Q&A 7 of the 280G Regulations, provided that this shall not require Executive to waive his rights to any payments or benefits that he is entitled to receive pursuant to the Equity Documents. 
 Section 8. Executive’s Representations, Warranties and Covenants. 
 (a) Executive hereby represents and warrants to the Company and its subsidiaries that: 
 (1) Executive has all requisite power and authority to execute and deliver this Agreement and to consummate the transactions contemplated hereby, and
this Agreement has been duly executed by Executive; 
 (2) the execution, delivery and performance of this Agreement by Executive does not
and will not, with or without notice or the passage of time, conflict with, breach, violate or cause a default under any agreement, contract or instrument to which Executive is a party or any judgment, order or decree to which Executive is subject;

 (3) Executive is not a party to or bound by any employment agreement, consulting agreement, non-compete agreement, fee for services
agreement, confidentiality agreement or similar agreement with any other Person other than the Company; 
 (4) upon the execution and
delivery of this Agreement by the Company and Executive, this Agreement will be a legal, valid and binding obligation of Executive, enforceable in accordance with its terms; 
 (5) Executive understands that Parent and the Company will rely upon the accuracy and truth of the representations and warranties of Executive set forth
herein and Executive consents to such reliance; and 
 (6) as of the date of execution of this Agreement, Executive is not in breach of any
of its terms, including having committed any acts that would form the basis for a Cause termination if such act had occurred after the Effective Date. 
 (b) The Company and its subsidiaries hereby represent and warrant to Executive that: 
 (1) the Company has
all requisite power and authority to execute and deliver this Agreement and to consummate the transactions contemplated hereby, and this Agreement has been duly executed by the Company; 
 (2) the execution, delivery and performance of this Agreement by the Company does not and will not, with or without notice or the passage of time,
conflict with, breach, violate or cause a default under any agreement, contract or instrument to which the Company is a party or any judgment, order or decree to which the Company is subject; 
  

 -9- 

 (3) upon the execution and delivery of this Agreement by the Company and Executive, this Agreement will
be a legal, valid and binding obligation of the Company, enforceable in accordance with its terms; and 
 (4) the Company understands that
Executive will rely upon the accuracy and truth of the representations and warranties of the Company set forth herein and the Company consents to such reliance. 
 Section 9. Indemnification. 
 The Company shall indemnify Executive to the maximum extent
permitted under the General Corporate Law of Delaware for acts taken within the scope of his employment. To the extent that the Company obtains coverage under a director and officer indemnification policy, Executive will be entitled to such coverage
on a basis that is no less favorable than the coverage provided to any other officer or director of the Company. 
 Section 10.
General Provisions. 
 (a) Severability. It is the desire and intent of the parties hereto that the provisions of this Agreement
be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of competent
jurisdiction to be invalid, prohibited or unenforceable under any present or future law, and if the rights and obligations of any party under this Agreement will not be materially and adversely affected thereby, such provision, as to such
jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction; furthermore, in lieu of such invalid or unenforceable
provision there will be added automatically as a part of this Agreement, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision as may be possible. Notwithstanding the foregoing, if such provision
could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the
validity or enforceability of such provision in any other jurisdiction. 
 (b) Entire Agreement. This Agreement and the Equity
Documents embody the complete agreement and understanding among the parties hereto with respect to the subject matter hereof and supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral,
which may have related to the subject matter hereof in any way (including, without limitation, any other employment, severance or change-in-control agreement or understanding). For the avoidance of doubt, Executive, the Company and the Subsidiaries
acknowledge that any agreement between Executive and the Company or Cendant Corporation or any subsidiary or affiliate of any of the foregoing, entered into prior to the Effective Date, including without limitation, the Prior Agreement, shall be
void ab initio as of immediately before the Effective Date. 
  

 -10- 

 (c) Counterparts. This Agreement may be executed in separate counterparts, each of which is deemed
to be an original and all of which taken together constitute one and the same agreement. 
 (d) Successors and Assigns. 
 (i) This Agreement is personal to Executive and without the prior written consent of the Company shall not be assignable by Executive otherwise than by
will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by Executive’s legal representatives. 
 (ii) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation
or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such
succession had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid that assumes and agrees to perform this Agreement by operation of
law, or otherwise. 
 (e) Governing Law. THIS AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
DELAWARE, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICTING PROVISION OR RULE (WHETHER OF THE STATE OF DELAWARE OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF DELAWARE TO BE APPLIED. IN
FURTHERANCE OF THE FOREGOING, THE INTERNAL LAW OF THE STATE OF DELAWARE WILL CONTROL THE INTERPRETATION AND CONSTRUCTION OF THIS AGREEMENT, EVEN IF UNDER SUCH JURISDICTION’S CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE LAW OF SOME
OTHER JURISDICTION WOULD ORDINARILY APPLY. 
 (f) Enforcement. 
 (i) Arbitration. Except for the Company or its Affiliate’s right to obtain injunctive relief for violation of Section 5 of this
Agreement or in Annex I to Section 8 of the Management Investor Rights Agreement, any controversy, dispute or claim arising out of or relating to this Agreement, or its interpretation, application, implementation, breach or enforcement which
the parties are unable to resolve by mutual agreement, shall be settled by submission by either party of the controversy, claim or dispute to binding arbitration in New York (unless the parties agree in writing to a different location), before a
single arbitrator in accordance with the Employment Dispute Resolution Rules of the American Arbitration Association then in effect. In any such arbitration proceeding the parties agree to provide all discovery deemed necessary by the arbitrator.
The decision and award made by the arbitrator shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court having jurisdiction thereof. Each party shall bear its or his costs and
expenses in any such arbitration and one-half of the arbitrator’s fees and costs; provided, however, if Executive prevails on substantially all material claims, the Company shall reimburse Executive for all of his reasonable
attorney’s fees and costs. 
  

 -11- 

 (ii) Remedies. All remedies hereunder are cumulative, are in addition to any other remedies
provided for by law and may, to the extent permitted by law, be exercised concurrently or separately, and the exercise of any one remedy shall not be deemed to be an election of such remedy or to preclude the exercise of any other remedy.

 (iii) Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT. 
 (g) Amendment and Waiver. The provisions of this Agreement
may be amended and waived only with the prior written consent of the Company and Executive and no course of conduct or failure or delay in enforcing the provisions of this Agreement shall be construed as a waiver of such provisions or affect the
validity, binding effect or enforceability of this Agreement or any provision hereof. 
 (h) Notices. Any notice provided for in this
Agreement must be in writing and must be either personally delivered, transmitted via telecopier, mailed by first class mail (postage prepaid and return receipt requested) or sent by reputable overnight courier service (charges prepaid) to the
recipient at the address below indicated or at such other address or to the attention of such other person as the recipient party has specified by prior written notice to the sending party. Notices will be deemed to have been given hereunder and
received when delivered personally, when received if transmitted via telecopier, five days after deposit in the U.S. mail and one day after deposit for overnight delivery with a reputable overnight courier service. 
 If to the Company, to: 
 Realogy Corporation 
 c/o Apollo Management VI, L.P. 
 9 West 57th Street 
 New York, New York 10019 
 Facsimile: (212) 515-3288 
 Attention: Marc Becker 
 with
a copy (which shall not constitute notice) to: 
 Wachtell, Lipton, Rosen & Katz 
 51 West 52nd Street 
 New York, NY 10019 

					
		 	Attention:	 	Steven A. Cohen, Esq.
		 		 	Igor Kirman, Esq.
		 	Facsimile:	 	212.403.2000

 If to Executive, to: 
 Executive’s home address most recently on file with the Company. 
  

 -12- 

 with a copy (which shall not constitute notice) to: 
 Simpson Thacher & Bartlett LLP 
 425 Lexington Avenue 
 New York, NY 10017 
 Attention: Andrea K. Wahlquist, Esq. 
 (i) Withholding. The Company may withhold from any amounts payable or benefits to be provided to Executive under this Agreement or otherwise all Federal, state, city or other taxes and other amounts that the Company may reasonably
determine are required to be withheld pursuant to any applicable law or regulation. 
 (j) Survival of Representations, Warranties and
Agreements. All representations, warranties and agreements contained herein shall survive this Agreement and the Employment Period indefinitely. 
 (k) Effectiveness. Notwithstanding the foregoing, none of Parent, the Company or its subsidiaries shall have any obligations to Executive or his beneficiaries under this Agreement, in the event Executive is
unable to perform his duties hereunder, including due to death or Disability or Executive commits an act that would constitute Cause, in each case prior to the closing of the Transaction, in which case this Agreement shall be of no force and effect.
Further, this Agreement shall be null and void and of no further effect in the event that the Merger Agreement is terminated or the Effective Date does not occur. 
 (l) Descriptive Headings. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a part of this Agreement. All references to a “Section” in this Agreement
are to a section of the Agreement unless otherwise noted. 
 (m) Construction. Where specific language is used to clarify by example a
general statement contained herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates. The language used in this Agreement shall be deemed to be the
language chosen by the parties to express their mutual intent, and no rule of strict construction shall be applied against any party. 
 (n)
Code Section 409A. Notwithstanding anything herein or elsewhere to the contrary, to the extent Executive or the Company notifies the other that this Agreement may result in Executive being subject to the penalties of Section 409A of
the Code, Executive and the Company agree to negotiate (and the Company shall cause any affiliate to negotiate), in good faith alternatives to avoid such penalties. 
  

 -13- 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written
above. 
  

			
	REALOGY CORPORATION
		
	By:	 	 /s/ David J. Weaving

	Name:	 	David J. Weaving
	Title:	 	 Executive Vice President and
 Chief Administrative
Officer

	
	RICHARD A. SMITH
		
	Signature:	 	 /s/ Richard A. Smith

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}]]